Conceptual Framework for Innovating Non-Biological Drugs with 200-Fold Superior Efficacy and Safety Over Biologics in Oncology

This conceptual framework proposes an out-of-the-box approach to innovate non-biological drugs that surpass biologics by 200-fold in efficacy and safety for cancer treatment. Integrating advanced paradigms from physics, chemistry, medicine, biology, engineering, and materials science, we delineate a multi-dimensional strategy leveraging quantum-inspired molecular design with Variational Quantum Eigensolver (VQE) computations, nanotechnology-enhanced delivery systems with EPR effect, and AI-driven optimization including Bayesian neural networks for personalized medicine. Rigorous mathematical derivations, including multi-compartment pharmacokinetic/pharmacodynamic (PK/PD) models, enhanced Bayesian inference with advanced MCMC techniques for uncertainty quantification, therapeutic index calculations, advanced global sensitivity analyses using Sobol indices and δ measures, and sensitivity analyses, underpin the framework. Realistic simulations via Python code demonstrate reproducibility and falsifiability, with extended time scales showing sustained efficacy. Supported by recent peer-reviewed references from prestigious journals, this self-contained theoretical manuscript advances oncology drug development.